# Howmet Aerospace Inc.: financial statements, quarterly

HWM · NYSE · CIK 4281 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hwm.md) · [Financials](/companies/hwm/financials.md) · [Filings](/companies/hwm/filings.md) · [Insiders](/companies/hwm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hwm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,731 d](/filings/0000004281-26-000012.md) | [1,824](/filings/0000004281-25-000019.md) | [1,880](/filings/0000004281-25-000033.md) | [1,835](/filings/0001628280-25-047584.md) | [1,891 d](/filings/0000004281-26-000012.md) | [1,942](/filings/0000004281-26-000019.md) | [2,053](/filings/0000004281-26-000025.md) | [2,089](/filings/0000004281-26-000036.md) | [2,168 d](/filings/0000004281-26-000012.md) | [2,313](/filings/0000004281-26-000019.md) | [2,547](/filings/0000004281-26-000025.md) | [2,703](/filings/0000004281-26-000036.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [9.0 d](/filings/0000004281-26-000012.md) | [10.0](/filings/0000004281-25-000019.md) | [7.0](/filings/0000004281-25-000033.md) | [9.0](/filings/0001628280-25-047584.md) | [7.0 d](/filings/0000004281-26-000012.md) | [8.0](/filings/0000004281-26-000019.md) | [9.0](/filings/0000004281-26-000025.md) | [10.0](/filings/0000004281-26-000036.md) | [10.0 d](/filings/0000004281-26-000012.md) | [9.0](/filings/0000004281-26-000019.md) | [8.0](/filings/0000004281-26-000025.md) | [11.0](/filings/0000004281-26-000036.md) |
| Selling, general and administrative | $m | [83.0 d](/filings/0000004281-26-000012.md) | [88.0](/filings/0000004281-25-000019.md) | [97.0](/filings/0000004281-25-000033.md) | [85.0](/filings/0001628280-25-047584.md) | [77.0 d](/filings/0000004281-26-000012.md) | [85.0](/filings/0000004281-26-000019.md) | [89.0](/filings/0000004281-26-000025.md) | [100](/filings/0000004281-26-000036.md) | [96.0 d](/filings/0000004281-26-000012.md) | [111](/filings/0000004281-26-000019.md) | [148](/filings/0000004281-26-000025.md) | [120](/filings/0000004281-26-000036.md) |
| Operating income | $m | [326 d](/filings/0000004281-26-000012.md) | [369](/filings/0000004281-25-000019.md) | [398](/filings/0000004281-25-000033.md) | [421](/filings/0001628280-25-047584.md) | [445 d](/filings/0000004281-26-000012.md) | [494](/filings/0000004281-26-000019.md) | [521](/filings/0000004281-26-000025.md) | [542](/filings/0000004281-26-000036.md) | [489 d](/filings/0000004281-26-000012.md) | [753](/filings/0000004281-26-000019.md) | [711](/filings/0000004281-26-000025.md) | [777](/filings/0000004281-26-000036.md) |
| Interest expense | $m | [52.0 d](/filings/0000004281-24-000007.md) | [49.0](/filings/0000004281-24-000014.md) | [49.0](/filings/0000004281-24-000026.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [34.0 d](/filings/0000004281-26-000012.md) | [60.0](/filings/0000004281-25-000019.md) | [68.0](/filings/0000004281-25-000033.md) | [22.0](/filings/0001628280-25-047584.md) | [78.0 d](/filings/0000004281-26-000012.md) | [102](/filings/0000004281-26-000019.md) | [62.0](/filings/0000004281-26-000025.md) | [110](/filings/0000004281-26-000036.md) | [58.0 d](/filings/0000004281-26-000012.md) | [128](/filings/0000004281-26-000019.md) | [115](/filings/0000004281-26-000025.md) | [154](/filings/0000004281-26-000036.md) |
| Net income | $m | [236 d](/filings/0000004281-26-000012.md) | [243](/filings/0000004281-25-000019.md) | [266](/filings/0000004281-25-000033.md) | [332](/filings/0001628280-25-047584.md) | [314 d](/filings/0000004281-26-000012.md) | [344](/filings/0000004281-26-000019.md) | [407](/filings/0000004281-26-000025.md) | [385](/filings/0000004281-26-000036.md) | [372 d](/filings/0000004281-26-000012.md) | [580](/filings/0000004281-26-000019.md) | [534](/filings/0000004281-26-000025.md) | [567](/filings/0000004281-26-000036.md) |
| Diluted EPS | $ per share | not reported | [0.59](/filings/0000004281-25-000019.md) | [0.65](/filings/0000004281-25-000033.md) | [0.81](/filings/0001628280-25-047584.md) | not reported | [0.84](/filings/0000004281-26-000019.md) | [1.00](/filings/0000004281-26-000025.md) | [0.95](/filings/0000004281-26-000036.md) | not reported | [1.44](/filings/0000004281-26-000019.md) | [1.33](/filings/0000004281-26-000025.md) | [1.42](/filings/0000004281-26-000036.md) |
| Basic EPS | $ per share | not reported | [0.59](/filings/0000004281-25-000019.md) | [0.65](/filings/0000004281-25-000033.md) | [0.81](/filings/0001628280-25-047584.md) | not reported | [0.85](/filings/0000004281-26-000019.md) | [1.01](/filings/0000004281-26-000025.md) | [0.96](/filings/0000004281-26-000036.md) | not reported | [1.45](/filings/0000004281-26-000019.md) | [1.33](/filings/0000004281-26-000025.md) | [1.42](/filings/0000004281-26-000036.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0000004281-25-000011.md) | [0.5](/filings/0000004281-24-000014.md) | [0.8](/filings/0000004281-24-000026.md) | [0.5](/filings/0000004281-24-000034.md) | [0.6](/filings/0000004281-26-000012.md) | [0.5](/filings/0000004281-25-000019.md) | [0.5](/filings/0000004281-25-000033.md) | [0.7](/filings/0001628280-25-047584.md) | [0.7](/filings/0000004281-26-000036.md) | [2.4](/filings/0000004281-26-000019.md) | [0.6](/filings/0000004281-26-000025.md) | [0.5](/filings/0000004281-26-000036.md) |
| Current assets | $bn | [3.3](/filings/0000004281-25-000011.md) | [3.3](/filings/0000004281-24-000014.md) | [3.6](/filings/0000004281-24-000026.md) | [3.4](/filings/0000004281-24-000034.md) | [3.4](/filings/0000004281-26-000012.md) | [3.6](/filings/0000004281-25-000019.md) | [3.7](/filings/0000004281-25-000033.md) | [3.8](/filings/0001628280-25-047584.md) | [3.8](/filings/0000004281-26-000036.md) | [5.7](/filings/0000004281-26-000019.md) | [4.2](/filings/0000004281-26-000025.md) | [4.1](/filings/0000004281-26-000036.md) |
| Total assets | $bn | [10.4](/filings/0000004281-25-000011.md) | [10.4](/filings/0000004281-24-000014.md) | [10.7](/filings/0000004281-24-000026.md) | [10.6](/filings/0000004281-24-000034.md) | [10.5](/filings/0000004281-26-000012.md) | [10.8](/filings/0000004281-25-000019.md) | [11.0](/filings/0000004281-25-000033.md) | [11.2](/filings/0001628280-25-047584.md) | [11.2](/filings/0000004281-26-000036.md) | [13.1](/filings/0000004281-26-000019.md) | [13.3](/filings/0000004281-26-000025.md) | [13.3](/filings/0000004281-26-000036.md) |
| Current liabilities | $bn | [1.8](/filings/0000004281-25-000011.md) | [1.7](/filings/0000004281-24-000014.md) | [2.4](/filings/0000004281-24-000026.md) | [1.5](/filings/0000004281-24-000034.md) | [1.5](/filings/0000004281-26-000012.md) | [1.5](/filings/0000004281-25-000019.md) | [1.6](/filings/0000004281-25-000033.md) | [1.6](/filings/0001628280-25-047584.md) | [1.8](/filings/0000004281-26-000036.md) | [2.3](/filings/0000004281-26-000019.md) | [2.3](/filings/0000004281-26-000025.md) | [2.2](/filings/0000004281-26-000036.md) |
| Total liabilities | $bn | [6.4](/filings/0000004281-25-000011.md) | [6.3](/filings/0000004281-24-000014.md) | [6.4](/filings/0000004281-24-000026.md) | [6.1](/filings/0000004281-24-000034.md) | [6.0](/filings/0000004281-26-000012.md) | [6.0](/filings/0000004281-25-000019.md) | [6.0](/filings/0000004281-25-000033.md) | [6.0](/filings/0001628280-25-047584.md) | [5.8](/filings/0000004281-26-000036.md) | [7.5](/filings/0000004281-26-000019.md) | [7.5](/filings/0000004281-26-000025.md) | [7.5](/filings/0000004281-26-000036.md) |
| Long-term debt | $bn | [3.5](/filings/0000004281-25-000011.md) | [3.5](/filings/0000004281-24-000014.md) | [2.9](/filings/0000004281-24-000026.md) | [3.4](/filings/0000004281-24-000034.md) | [3.3](/filings/0000004281-26-000012.md) | [3.3](/filings/0000004281-25-000019.md) | [3.3](/filings/0000004281-25-000033.md) | [3.2](/filings/0001628280-25-047584.md) | [2.9](/filings/0000004281-26-000036.md) | [4.1](/filings/0000004281-26-000019.md) | [4.1](/filings/0000004281-26-000025.md) | [4.1](/filings/0000004281-26-000036.md) |
| Current portion of debt | $bn | [0.2](/filings/0000004281-25-000011.md) | [0.2](/filings/0000004281-24-000014.md) | [0.8](/filings/0000004281-24-000026.md) | [0.0](/filings/0000004281-24-000034.md) | [0.0](/filings/0000004281-26-000012.md) | [0.0](/filings/0000004281-25-000019.md) | [0.0](/filings/0000004281-25-000033.md) | [0.0](/filings/0001628280-25-047584.md) | [0.2](/filings/0000004281-26-000036.md) | [0.2](/filings/0000004281-26-000019.md) | [0.0](/filings/0000004281-26-000025.md) | [0.0](/filings/0000004281-26-000036.md) |
| Short-term borrowings | $bn | not reported | not reported | [0.0](/filings/0000004281-24-000026.md) | [0.0](/filings/0000004281-24-000034.md) | [0.0](/filings/0000004281-26-000012.md) | [0.0](/filings/0000004281-25-000019.md) | [0.0](/filings/0000004281-25-000033.md) | [0.0](/filings/0001628280-25-047584.md) | [0.0](/filings/0000004281-26-000036.md) | [0.5](/filings/0000004281-26-000019.md) | [0.5](/filings/0000004281-26-000025.md) | [0.4](/filings/0000004281-26-000036.md) |
| Shareholders' equity | $bn | [4.0](/filings/0000004281-26-000012.md) | [4.1](/filings/0000004281-25-000033.md) | [4.3](/filings/0001628280-25-047584.md) | [4.5](/filings/0001628280-25-047584.md) | [4.6](/filings/0000004281-26-000036.md) | [4.8](/filings/0000004281-26-000025.md) | [5.0](/filings/0000004281-26-000036.md) | [5.1](/filings/0000004281-26-000036.md) | [5.4](/filings/0000004281-26-000036.md) | [5.5](/filings/0000004281-26-000025.md) | [5.7](/filings/0000004281-26-000036.md) | [5.8](/filings/0000004281-26-000036.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper, us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [458 d](/filings/0000004281-26-000012.md) | [177](/filings/0000004281-25-000019.md) | [397 d](/filings/0000004281-25-000033.md) | [244 d](/filings/0001628280-25-047584.md) | [480 d](/filings/0000004281-26-000012.md) | [253](/filings/0000004281-26-000019.md) | [446 d](/filings/0000004281-26-000025.md) | [531 d](/filings/0000004281-26-000036.md) | [654 d](/filings/0000004281-26-000012.md) | [453](/filings/0000004281-26-000019.md) | [583 d](/filings/0000004281-26-000025.md) | [709 d](/filings/0000004281-26-000036.md) |
| Capital expenditure | $m | [55.0 d](/filings/0000004281-26-000012.md) | [82.0](/filings/0000004281-25-000019.md) | [55.0 d](/filings/0000004281-25-000033.md) | [82.0 d](/filings/0001628280-25-047584.md) | [102 d](/filings/0000004281-26-000012.md) | [119](/filings/0000004281-26-000019.md) | [102 d](/filings/0000004281-26-000025.md) | [108 d](/filings/0000004281-26-000036.md) | [124 d](/filings/0000004281-26-000012.md) | [94.0](/filings/0000004281-26-000019.md) | [104 d](/filings/0000004281-26-000025.md) | [147 d](/filings/0000004281-26-000036.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [100 d](/filings/0000004281-26-000012.md) | [150](/filings/0000004281-25-000019.md) | [60.0 d](/filings/0000004281-25-000033.md) | [100 d](/filings/0001628280-25-047584.md) | [190 d](/filings/0000004281-26-000012.md) | [125](/filings/0000004281-26-000019.md) | [175 d](/filings/0000004281-26-000025.md) | [200 d](/filings/0000004281-26-000036.md) | [200 d](/filings/0000004281-26-000012.md) | [300](/filings/0000004281-26-000019.md) | [300 d](/filings/0000004281-26-000025.md) | [500 d](/filings/0000004281-26-000036.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [418](/filings/0000004281-24-000014.md) | [417](/filings/0000004281-24-000026.md) | [415](/filings/0000004281-24-000034.md) | [412](/filings/0000004281-25-000019.md) | [411](/filings/0000004281-25-000033.md) | [410](/filings/0001628280-25-047584.md) | [407](/filings/0000004281-26-000019.md) | [406](/filings/0000004281-26-000025.md) | [405](/filings/0000004281-26-000036.md) | [403](/filings/0000004281-26-000019.md) | [402](/filings/0000004281-26-000025.md) | [400](/filings/0000004281-26-000036.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 397,660,490 at 2026-10-26, from the cover of the [10-Q filed 2026-10-29](/filings/0000004281-26-000036.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 19:05 ET. No prices; not investment advice.